HOUSTON, TX -- (Marketwire) -- 06/21/12 -- MicroMed Cardiovascular Inc., manufacturer of the HeartAssist 5 Left Ventricular Assist Device (LVAD), recently integrated the capacity for continuous wireless monitoring into its Conquest Controller. The Conquest Controller release is pending approval by regulatory agencies.
This unprecedented innovation will allow continual remote monitoring of data from the Heart Assist 5 LVAD. As a result, clinicians, doctors and technicians will be informed automatically and in the background without requiring the patient to do anything or having to come in to the clinic or hospital facilities.
Prior to MicroMed's implementation of the M2M technology, clinicians could only access device data when the patient physically plugged the HeartAssist 5 into MicroMed's HeartAttendant so that data could be transmitted via a local internet connection. The internet solution provided useful data, but limited patient mobility, and meant data reporting could not be continuous.
Sailesh Saxena, MicroMed's CFO said, "As the only provider of such wireless remote monitoring, MicroMed is expected to enhance patients' peace of mind while providing caregivers and patients an opportunity to avoid some expensive and time consuming visits to the hospital for issues that could be managed at home." He said further, "It is expected that the benefits of MicroMed's unique remote monitoring solution will be eagerly documented as they are revealed."
The HeartAssist 5 was originally developed by the world famous heart surgeon Dr. Michael DeBakey in partnership with NASA. It is the smallest and lightest full support LVAD in the world, weighing only 92 grams, and is nearly silent. Because of its miniature size, it is one of the few LVADs that can be implanted above the diaphragm, adjacent to the heart, and is the most technically advanced device among a small number of competitors in this field. It is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring. The HeartAssist 5 System consists of two devices: MicroMed HeartAssist 5 LVAD and the MicroMed Controller.
MicroMed's Conquest M2M application was built as a joint partnership with Numerex Corp (NASDAQ: NMRX) using the secure, reliable Numerex FAST platform. This resulted in significant cellular cost savings and allowed remote monitoring of the device to be constant and consistent, resulting in relevant reporting around the clock.
"The partnership with Numerex has been spectacular. They provided the expertise we need along with their Numerex DNA® solution to move our idea quickly and reliably to market," said Bryan Lynch, Vice President of product development at MicroMed.
About MicroMed Cardiovascular Inc.
MicroMed is a pioneer in the accelerating field of Mechanical Circulatory Support. Using advanced technologies, MicroMed manufactures the powerful, miniature, implantable electric HeartAssist 5 Left Ventricular Assist Device that increases the cardiac output of a failing heart. The Next Generation HeartAssist 5® system is currently sold commercially outside of the United States and the wireless system is not yet approved for human use. www.micromedcv.com
Numerex Corp (NASDAQ: NMRX) is a leading provider of machine-to-machine (M2M) business services, technology, and products used in the development and support of M2M solutions for the enterprise and government markets worldwide. The Company offers Numerex DNA® that includes hardware and smart Devices, cellular and satellite Network services, and software Applications that are delivered through Numerex FAST® (Foundation Application Software Technology). Customers typically subscribe to device management, network, and application services through hosted platforms. Business services enable the development of efficient, reliable, and secure solutions while simplifying and speeding up deployment through streamlined processes and comprehensive integration services. Numerex is ISO 27001 information security-certified. "Machines Trust Us®" represents the Company's focus on M2M data security, service reliability, and round-the-clock support of its customers' M2M solutions.